Stay updated on Biomarker Analysis in High PD-L1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page.

Latest updates to the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page
- Check7 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and 'HHS Vulnerability Disclosure' along with the previous 'Revision: v3.3.2' were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe Record History now includes a new revision entry: v3.3.2 has been added. The previous revision v3.3.1 has been removed.SummaryDifference0.1%

- Check35 days agoChange DetectedThe Record History shows an added Revision v3.3.1 and the removal of Revision v3.2.0.SummaryDifference0.1%

- Check43 days agoChange DetectedNotice about lapse in government funding and potential delays was removed, eliminating guidance on operating status and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check57 days agoChange DetectedVersion history shows updates to Recruitment Status and Study Status across versions 2–5, and the latest version includes a Study Design change.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.SummaryDifference13%

Stay in the know with updates to Biomarker Analysis in High PD-L1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Analysis in High PD-L1 NSCLC Clinical Trial page.